Skip to content

Invitation to Orion's Capital Markets Day on 26 May 2015

Orion Corporation has the pleasure to invite analysts, institutional investors and media to its Capital Markets Day 2015 on Tuesday, 26 May 2015. The event will be held at Finlandia Hall, Mannerheimintie 13, Helsinki (Veranda, ground floor).

Preliminary agenda (subject to change)

8.15 Registration and breakfast
8.55 Opening remarks
Tuukka Hirvonen, Communications Manager - IR & Financial Communications
9.00 CEO's presentation
Timo Lappalainen, President & CEO
  R&D pipeline review, part I
Reijo Salonen, SVP Research & Development
10.00 Break
10.15 Proprietary Products update
Markku Huhta-Koivisto, SVP Proprietary Products
  Specialty Products update
Liisa Hurme, SVP Specialty Products
  CFO's presentation
Jari Karlson, CFO
11.35 Break
11.45 Animal Health
Niclas Lindstedt, Vice President
  Fermion
Arto Toivonen, President
  Orion Diagnostica
Jaakko Rissanen, President
  R&D pipeline review, part II
Reijo Salonen, SVP Research & Development
13.00 Lunch and discussion with management
14.30 Event ends

The presentations can also be followed through live webcast at www.orion.fi/en/investors. The presentation materials will be available on Orion website during the day and recordings of the presentations latest on the following day.

Please register to the event by email: ir@orion.fi or by tel. +358 10 426 2169 / +358 10 426 2721 no later than on Friday 15 May 2015 at 3.00 p.m. EEST.

Participants should be prepared to present a photo ID on request.  

We hope you and your colleagues will take the opportunity to participate, and we look forward to meeting you there.

Yours sincerely,

Timo Lappalainen
President and CEO

Travel and accommodation
In order to assist you, we have reserved a quota of hotel rooms at Hotel Scandic Park which is a short walking distance from the venue Finlandia Hall. The rate for single room is EUR 134 and for double room EUR 154 (check in on May 25, check out May 26). Please refer to booking reference ORI250515 when making your reservation.

Scandic Park Helsinki, Mannerheimintie 46
Tel: +358 9 47 371
E-mail: parkhelsinki@scandichotels.com
http://www.scandichotels.com/

Participants are kindly asked to book their own flights and arrange transportation from and to the airport. Please note that Orion does not cover any costs for travelling or accommodation.

For further information, please contact:
Tuukka Hirvonen, Communications Manager, tel. +358 10 426 2721 or tuukka.hirvonen@orion.fi

Publisher:
Orion Corporation
www.orion.fi/en
www.orion.fi/en/investors

Orion is a globally operating Finnish company developing pharmaceuticals and diagnostic tests - a builder of well-being. Orion develops, manufactures and markets human and veterinary pharmaceuticals, active pharmaceutical ingredients and diagnostic tests. The company is continuously developing new drugs and treatment methods. The core therapy areas of Orion's pharmaceutical R&D are central nervous system (CNS) disorders, oncology and respiratory for which Orion developes inhaled Easyhaler® pulmonary drugs.

Orion's net sales in 2014 amounted to EUR 1,015 million and the company had about 3,500 employees. Orion's A and B shares are listed on NASDAQ Helsinki.